In patients with type 2 diabetes, postprandial plasma IL-6 concentrations were lower when circulating insulin levels were approximately 2-fold higher during a test meal breakfast in those who were receiving pre-meal insulin therapy thrice daily compared with those who were receiving insulin only at bedtime [12]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.